Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.7.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
4 Months Ended
Jun. 24, 2016
Jan. 01, 2016
Oct. 21, 2015
Dec. 20, 2013
Jun. 30, 2017
Jun. 30, 2016
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]            
Lease payments         $ 5,668 $ 7,167
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]            
Monthly lease payments         11,042 11,042
Lease payments         44,168 44,168
Property taxes paid         16,236 15,825
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]            
Amortization of deferred compensation cost         $ 0 7,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]            
Number of shares issued upon agreement       420,000    
Share price (in dollars per share)       $ 0.20    
Agreement term       3 years    
Consulting Agreement [Member] | Mr. Cyril Narishkin [Member]            
Monthly payment for agreement   $ 16,000 $ 16,000      
Description of payment terms  

Seventy-five percent was to be paid in cash and twenty-five percent was to be paid in shares of common stock.

Half was to be paid in cash and half was to be paid in shares of common stock.

     
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]            
Monthly payment for agreement $ 16,000          
Number of shares repurchased         96,542  
Value of shares repurchased         $ 43,393  
Officer compensation         $ 0 $ 118,000